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Association between atrial 
fibrillation, atrial enlargement, 
and left ventricular geometric 
remodeling
Yuta Seko1, Takao Kato2, Tetsuya Haruna1, Toshiaki Izumi1, Shoichi Miyamoto1,  
Eisaku Nakane1 & Moriaki Inoko1
This study investigated the relationship between atrial fibrillation (AF) and left ventricular (LV) 
geometric patterns in a hospital-based population in Japan. We retrospectively analyzed 4444 
patients who had undergone simultaneous scheduled transthoracic echocardiography (TTE) and 
electrocardiography during 2013. A total of 430 patients who had findings of previous myocardial 
infarctions (n = 419) and without the data on body surface area (n = 11) were excluded from the study. 
We calculated the LV mass index (LVMI) and relative wall (RWT) and categorized 4014 patients into four 
groups as follows: normal geometry (n = 3046); concentric remodeling (normal LVMI and high RWT, 
n = 437); concentric hypertrophy (high LVMI and high RWT, n = 149); and eccentric remodeling (high 
LVMI and normal RWT, n = 382). The mean left atrial volume indices (LAVI) were 22.5, 23.8, 33.3, and 
37.0 mm/m2 in patients with normal geometry, concentric remodeling, concentric hypertrophy, and 
eccentric hypertrophy, respectively. The mean LV ejection fractions (LVEF) were 62.7, 62.6, 60.8, and 
53.8%, respectively, whereas the prevalence of AF was 10.4%, 10.5%, 14.8%, and 16.8% in patients 
with normal geometry, concentric remodeling, concentric hypertrophy, and eccentric hypertrophy, 
respectively. In conclusion, the prevalence of AF was increasing according to LV geometric remodeling 
patterns in association with LA size and LVEF.
Left ventricular (LV) hypertrophy (LVH) may be considered a compensatory effect since increasing LV wall thick-
ness reduces LV wall stress1. However, as LVH progresses, it is associated with considerable cardiovascular (CV) 
morbidity and mortality2,3. Recent studies have focused on the prognostic impact of more subtle LV geomet-
ric abnormalities. Patterns of LVH and geometric remodeling have previously been investigated extensively in 
patients with hypertension and valvular heart diseases4,5. Concentric LVH has a high mortality risk with pre-
served ejection fraction (EF)6,7 or a high mortality risk in patients without regression of abnormal LV geometry8; 
other studies have reported that relative wall thickness has less impact on prognosis in patients with coronary 
heart disease3.
LVH and LV dilatation cause an in increase in end-diastolic pressure, followed by enlargement of the left 
atrium9. Atrial fibrillation (AF) is more prevalent among older people with pronounced morbidity and mortal-
ity10–13. AF can cause heart failure, affect quality of life, lengthen the hospitalization period, and increase mortal-
ity14. Left atrial (LA) remodeling, LA enlargement, and LV remodeling are related to AF development15. However, 
the association between LV geometric patterns, LA enlargement, and AF remains unknown. Therefore, in this 
study, we investigated the association between LV geometric patterns, LA enlargement, and AF.
Methods
Study population. We retrospectively analyzed 4444 patients who had undergone simultaneous scheduled 
transthoracic echocardiography (TTE) and electrocardiography (ECG) at the Cardiovascular Center of Kitano 
Hospital during 2013. A flowchart of the study population is shown in Fig. 1. A total of 430 patients who had 
findings of previous myocardial infarctions (n = 419) and without the data on body surface area (n = 11) were 
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excluded from the study, because the old myocardial infarction affected their wall thickness and other data from 
the TTE. On the basis of the data from the TTE and ECG examinations in addition to the catheter database, we 
identified patients who had a previous myocardial infarction. The ECG and TTE were ordered by each physician.
The research protocol was approved by the institutional review board of Kitano Hospital (approval no.: P16-
02-005). Informed consent was not obtained from each patient since this was a retrospective study. The study pro-
tocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki as reflected in a priori approval by the 
institution’s human research committee. Patients’ records and information were anonymized and de-identified 
before analysis.
Data collection. From the TTE database, we extracted data for patients’ wall thickness, LV diastolic diameter 
(LVDd), E/e’, LA diameter (LAD), LA volume index (LAVI), and LV ejection fraction (LVEF). We also extracted 
the body surface area from the TTE report. From the ECG database, we extracted cardiac rhythm and recorded it 
as it was documented. Therefore, we could not determine whether the AF was paroxysmal or persistent.
The LV mass was calculated using the formula recommended by the American Society of Echocardiography 
(ASE), and it was indexed to the body surface area as follows: LV mass = 0.8 × 1.04 [(LVDd + LVPWTd + IVST
d)3 − (LVDd)3] + 0.6, where LVDd was the LV diastolic diameter, IVSTd was the diastolic interventricular septal 
wall thickness, and LVPWTd was the diastolic LV posterior wall thickness. In line with the ASE recommenda-
tions, a high LV mass index (LVMI) was defined as >115 g/m2 for male patients and >95 g/m2 for female patients. 
Relative wall thickness (RWT) was calculated using the following formula: (2 × LVPWTd)/(LVDd), which per-
mits physicians to categorize an increase in the LV mass as either concentric (RWT >0.42) or eccentric (RWT 
≤0.42) hypertrophy and identify concentric remodeling (a normal LV mass with an increased RWT)16,17. The 
LAVI was calculated using the biplane area-length method and body surface area and defined high as a value 
>42 mL/m214,15. Data from two-dimensional TTE were analyzed at baseline. The LVEF was measured using the 
Teichholz method or the modified Simpson rule method and defined low as LVEF <50%.
We then categorized 4014 patients into four groups as follows (Fig. 1): normal geometry (n = 3046), concen-
tric remodeling (normal LVMI and high RWT, n = 437), concentric hypertrophy (high LVMI and high RWT, 
n = 149), and eccentric hypertrophy (high LVMI and normal RWT, n = 382).
We extracted patients’ data from the electronic medical data at our institution, including age, sex, and type of 
disease, i.e., hypertension (International Statistical Classification of Diseases and Related Health Problems, Tenth 
Edition [ICD-10] codes I10, I11, I12, I13, I14, and I15), hyperlipidemia (ICD-10 code E78), diabetes mellitus 
(ICD-10 codes E10, E11, E12, E13, and E14), and chronic kidney disease (CKD) (ICD-10 code N18), from elec-
tronic medical data at our institution.
Data availability. The datasets generated during and/or analyzed during the current study are available from 
the corresponding author on reasonable request.
Statistical analysis. Categorical variables are presented as numbers and percentages, and were compared 
using the chi-square test or Fisher exact test. Continuous variables are expressed as a mean ± standard deviation 
or median (interquartile range). Based on their distributions, continuous variables were compared using the 
Student t-test or Wilcoxon rank-sum test. To analyze factors associated with AF, we used a multivariable logistic 
regression model (model 1) involving the following potential independent, clinically relevant variables: age >70 
years; sex; LV geometric remodelings that was defined as ordered variables (normal geometry, concentric remod-
eling, concentric hypertrophy, and eccentric hypertrophy); and the presence of comorbidities such as ishemic 
heart disease, hypertension, diabetes mellitus, hyperlipidemia, CKD and overweight (body mass index >25 kg/
m2). The adjusted odds ratios and 95% confidence intervals were calculated. To show the association of two varia-
bles (LAD and LVMI, LAD and RWT, LVEF and LVMI, and LVEF and RWT), we presented scatter plots, lines of 
best fit, and correlation coefficients. To visualize the effect size of each variable, the LogWorth (−log10(p-value)) 
Figure 1. Flowchart of the study population. Abbreviations: TTE = transthoracic echocardiography; 
ECG = electrocardiography; LV = left ventricular; LVMI = LV mass index; RWT = relative wall thickness; and 
OMI = old myocardial infarction.
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scales were presented18. In LogWorth sclaes, a highly significant p-value had a large LogWorth value and a non-
significant p-value had a low LogWorth value18. We generated the second multivariable regression model (model 
2) including the LA size and LVEF to visualize the effect size of the LA size and LVEF as the LogWorth scales. In 
addition, we generated a multivariable logistic regression model using the same variables in AF for adjustment to 
analyze factors associated with a high LAVI and a low LVEF. Finally, from a logistic regression model with nomi-
nal responses (AF or not) using LVEF and LAVI, we generated a formula for linear combinations of the response 
levels (x = a + b x LVEF + c x LAVI) and prediction formulas for the response levels predicting the presence of 
AF (1/ (1 + Exp(x)) and the absence of AF (1/(1 + EXP(-x)), then we compared the two levels and predicted the 
presence or absence of AF according to the larger response level. We showed a receiver-operating curve with an 
area under the curve and provided the sensitivity and 1-specificity of this prediction formulas.
All statistical analyses were performed using JMP, version 13.2 (SAS Institute Inc., Chicago, IL, USA).
Results
Patients’ characteristics according to the LV geometric patterns. Baseline characteristics of 
patients are provided in Table 1. Among patients’ characteristics, patients with a normal geometry were signif-
icantly younger than who had abnormal geometry. The ratio of men were 52.4%, 58.3%, 48.3%, and 45.0% in 
patients with a normal geometry, concentric remodeling, concentric hypertrophy, and eccentric hypertrophy, 
respectively. Patients with concentric remodeling, concentric hypertrophy, and eccentric hypertrophy had high 
rates of hypertension, hyperlipidemia, diabetes mellitus, aortic valve stenosis, and CKD (Table 1).
Baseline characteristics of echocardiography. Baseline characteristics of echocardiographic findings 
are provided in Table 2. The mean LVEFs were 62.7, 62.6, 60.8, and 53.8% in patients with a normal geometry, 
concentric remodeling, concentric hypertrophy, and eccentric hypertrophy, respectively. The mean LAVIs were 
22.5, 23.8, 33.3, and 37.0 mm/m2 in patients with a normal geometry, concentric remodeling, concentric hyper-
trophy, and eccentric hypertrophy, respectively.
Prevalence of AF. Overall, 3460 patients had a normal sinus rhythm, 455 had AF, 95 had a pacemaker 
rhythm, and 15 had other rhythms. The prevalence rates of AF were 10.4, 10.5, 14.8, and 16.8% in patients with 
a normal geometry, concentric remodeling, concentric hypertrophy, and eccentric hypertrophy, respectively 
(p < 0.0001, Fig. 2).
Association among LV geometry, LA size, and LVEF. In order to investigate the underlying link 
between AF and LV geometry, we evaluated the relationship between LVMI, RWT, LVD, and LVEF. By using 
scatter plots, we visualized the association (Fig. 3). LAD was significantly related to the high LVMI (Fig. 3A). In 
contrast, LAD was small but positively related to high RWT when LVMI was normal (Fig. 3B), and negatively 














(n = 382) p
Age, yr, SD 66.3, 15.9 64.5, 16.3 72.8, 12.1 71.9, 12.6 70.3, 13.6 <0.0001
Male, % 52.2 52.4 58.3 48.3 45.0 0.0014
Diabetes, % 29.9 27.3 40.3 45.6 33.0 <0.0001
Hypertension, % 57.0 50.6 74.4 89.3 76.7 <0.0001
Hyperlipidemia, % 29.0 26.6 36.6 42.3 35.1 <0.0001
Aortic stenosis, % 3.2 1.3 11.0 11.4 5.8 <0.0001
Aortic regurgitation, % 3.1 2.0 1.1 9.4 11.5 <0.0001
Mitral stenosis, % 0.2 0.2 0.2 0.7 0.5 0.340
Mitral regurgitation, % 3.6 2.5 1.8 4.7 13.0 <0.0001
Chronic kidney disease, % 14 10.5 20.1 38.9 25.9 <0.0001
Overweight, % 27.7 26.9 30.1 33.6 29.6 0.1419










(n = 382) p
LVDd, mm 46.7, 6.1 46.4, 4.8 40.7, 4.1 46.2, 4.9 55.6, 7.6 <0.0001
E/e’ 11.6, 4.8 10.8, 4.1 13.3, 5.4 17.3, 7.0 14.3, 5.7 <0.0001
LAD, mm 35.6, 7.0 34.7, 6.5 35.4, 6.8 40.0, 7.3 41.1, 7.7 <0.0001
LAVI, ml/m2 24.4, 14.8 22.5, 12.9 23.8, 12.5 33.3, 17.2 37.0, 21.6 <0.0001
LVEF, % 61.7, 7.6 62.7, 6.0 62.6, 4.9 60.8, 7.5 53.8, 14.5 <0.0001
Table 2. Baseline transthoracic echocardiography results. Abbreviations: LVDd = left ventricular diastolic 
dimension; LAD = left atrial diameter; LAVI = left atrial volume index; LVEF = LV ejection fraction.
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(Fig. 3C). With regards to RWT, LVEF was only slightly correlated with RWT when LVMI was normal (Fig. 3D), 
but positively correlated with RWT when LVMI was high (Fig. 3D), showing that the relationship between LVEF 
and RWT was different for normal and high LVMI.
Factors associated with AF and underlying LA enlargement and a low LVEF. According to the 
results of the multivariate logistic regression analysis (model 1, Fig. 4A), the following variables were significantly 
associated with AF: age >70 years, male sex, hypertension, and LV geometric patterns (Table 3 and Fig. 4B). 
When we included two additional echocardiographic parameters, LA enlargement (LAD >40 mm) and a low 
LVEF (LVEF <50%), into a multivariate model for the presence of AF (model 2, Fig. 4C), LA enlargement was the 
echocardiographic parameter most associated with AF, and a low LVEF was the second most associated parame-
ter (Fig. 4D), superior to the LV geometry. Finally, we sought the associated factors for LA enlargement and low 
LVEF. Table 4 shows the significant association with LV geometry and a high LAVI or LVEF. Finally, the presence 
of AF was well predicted by the values of LAVI and LVEF by receiver operating curve analysis (area under the 
curve 0.87; Fig. 4F). These indicated that the LV morphology was linked to the LV function and LA size (sche-
matic in Fig. 4F).
Figure 2. Prevalence of atrial fibrillation (AF) with each geometry patients.
Figure 3. Association with LVMI, RWT, LA diameter, and LVEF. (A) Association between LVMI and LA 
diameter (LAD). Scatter plots show the positive correlation between LVMI and LAD. R2 = 0.24, p < 0.001. 
R = correlation coefficient. (B) Association between RWT and LAD. In patients with normal LVMI (left panel), 
scattered plots showed small correlation between RWT and LA diameter. R2 = 0.007, p < 0.001. In high LVMI 
(right panel), scatter plots showed small but, negative correlation between RWT and LA diameter. R2 = 0.020, 
p = 0.0010. (C) Association between LVMI and LVEF. Scatter plots showed the negative correlation between 
LVMI and LVEF. R2 = 0.14, p < 0.001. (D) Association between RWT and LVEF. In normal LVMI (left panel), 
scatter plots showed small correlation between RWT and LVEF. R2 = 0.002, p = 0.0029. In high LVMI (right 
panel), scatter plots showed small but, positive correlation between RWT and LVEF. R2 = 0.160, p < 0.001.
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Discussion
The main finding of the present study was that the prevalence of AF increased per the geometric remodeling pat-
terns. The mechanism for why the prevalence of AF increased is unclear; however, cardiac remodeling manifests 
as changes in the cardiac size, shape, and function in response to aging, cardiac impairment, or an increased load9. 
Cardiac remodeling causes an increase in end-diastolic pressure and expansion of end-diastolic volume with dias-
tolic and systolic dysfunction9. In the present study, patients with concentric remodeling, concentric hypertrophy, 
and eccentric hypertrophy were older than those with a normal geometry. In addition, patients with concentric 
remodeling, concentric hypertrophy, and eccentric hypertrophy had a higher E/e’. E/e’ is highest in patients with 
concentric hypertrophy17.
Concentric remodeling and hypertrophy were often caused by pressure overload that increased the RWT. 
This was an adaptation to normalize the systolic wall stress. However, LV was shown to be a substrate for LV 
diastolic dysfunction in concentric remodeling and an incremental risk for diastolic heart failure in concentric 
Figure 4. (A) Model 1 in Table 3 includes factors included age >70 years; sex; LV geometric remodelings 
that were defined as ordered variables (normal geometry, concentric remodeling, concentric hypertrophy, 
and eccentric hypertrophy); and the presence of comorbidities such as ischemic heart disease (IHD), 
hypertension (HT), diabetes mellitus (DM), hyperlipidemia (HLP), CKD and overweight (body mass index 
>25 kg/m2). (B) LogWorth scales of multivariate model 1 in Table 3. The p-values were transformed to the 
LogWorth (−log10(p-value)) scale. Hence, any LogWorth above 2 corresponds to a p-value below 0.01. A 
LogWorth of zero corresponds to a nonsignificant p-value of 1. (C) Model 2 includes factors included as 
factors for model 1, as well as left atrial enlargement [LAD (left atrial diameter) >40 mm] and low LVEF 
(EF <50%). (D) LogWorth scales of multivariate model 2. (E) Results of receiver operating characteristic 
(ROC) curve analysis. For predicting the presence of AF, the formula was generated from a linear regression 
(x = 3.55296 + 0.0208 × LVEF +− 0.09732 × LAVI). The prediction formulas for the response levels predicting 
the presence of AF and the absence of AF were (1/(1 + Exp(x)) and (1/(1 + EXP(−x)), respectively. Then 
we compared the two levels and predicted the presence or absence of AF according to the larger response 
level. The ROC curve shows an area under the curve of 0.871, and when x = 2.1433, the sensitivity is 0.8044 
and 1-specificity is 0.6042. (F) A proposed schema for the relationship between LV geometry, LVEF, LA 
enlargement, and AF.
www.nature.com/scientificreports/
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hypertrophy. Direct underlying triggers of AF was mainly due to atrial remodeling. Atrial remodeling is caused by 
multiple factors19. The left atrium is a thin-walled structure that connects the pulmonary veins and LV in diastole 
and pumps the LV (atrial kick) in end-diastole during sinus rhythm15. Previous work has highlighted the complex 
mechanisms contributing to AF progression19–23, as the morphological, electrical, or neurohormonal remodeling 
along with the ventricular responses were related. Diastolic impairment and an increasing diastolic filling pres-
sure are related to the LA size. With an increase in LA filling pressures, the atrial wall stretches and enlarges. In 
this study, overweight was not significantly associated with AF, which was inconsistent with the previous stud-
ies24. One of the reasons may be the differences in baseline characteristics in Japanese population and in Western 
population. Body weights in Japan are much lower than those in the US and Europe. Other possible reason may 
be due to small numbers studied in our study, considering that a marginally significance existed.
AF
Multivariate OR 95% CI P
Age >70 years 2.16 1.75–2.68 <0.0001
Male sex 1.67 1.35–2.06 <0.0001
HT 2.22 1.74–2.84 <0.0001
DM 1.00 0.80–1.24 0.987
CKD 0.77 0.57–1.02 0.078
HLP 0.94 0.75–1.18 0.615
Overweight 1.18 0.99–1.47 0.13
LV geometry
Normal geometry 1 (Reference)
Concentric remodeling 0.75 0.53–1.03 0.085
Concentric hypertrophy 1.10 0.66–1.75 0.683
Eccentric hypertrophy 1.45 1.06–1.96 0.018
Concentric remodeling 1 (Reference)
Concentric hypertrophy 1.47 0.83–2.54 0.179
Eccentric hypertrophy 1.96 1.28–2.94 0.001
Concentric hypertrophy 1 (Reference)
Eccentric hypertrophy 1.31 0.78–2.28 0.309
Table 3. Factors associated with AF according to multivariate logistic regression analysis. Abbreviations: 
OR = odds ratio; CI = confidence interval; RWT = relative wall thickness; LVMI = left ventricular mass index; 
HT = hypertension; DM = diabetes mellitus; CKD = chronic kidney disease, HLP = Hyperlipidemia.
A high LAVI A low LVEF
Multivariate OR 95% CI P Multivariate OR 95% CI p
Age >70 years 3.29 2.43–4.47 <0.0001 0.85 0.63–1.14 0.288
Male sex 0.95 0.73–1.25 0.751 2.14 1.55–2.94 <0.0001
HT 2.14 1.53–2.99 <0.0001 4.60 2.93–7.23 <0.0001
DM 1.19 0.89–1.60 0.242 1.08 0.78–1.49 0.623
CKD 0.95 0.67–1.35 0.789 1.07 0.74–1.53 0.705
HLP 0.658 0.47–0.89 0.007 1.24 0.91–1.70 0.166
Overweight 0.91 0.68–1.24 0.574 0.72 0.51–0.99 0.045
LV geometry
Normal geometry 1 (Reference) 1 (Reference)
Concentric remodeling 1.03 0.66–1.61 0.872 0.41 0.19–0.86 0.018
Concentric hypertrophy 3.36 2.05–5.51 <0.0001 1.48 0.74–2.96 0.259
Eccentric hypertrophy 5.77 4.20–7.98 <0.0001 11.3 8.18–15.5 <0.0001
Concentric remodeling 1 (Reference) 1 (Reference)
Concentric hypertrophy 3.24 1.77–5.94 0.0001 3.59 1.37–9.37 0.008
Eccentric hypertrophy 5.56 3.44–8.99 <0.0001 27.5 13.1–57.9 <0.001
Concentric hypertrophy 1 (Reference) 1 (Reference)
Eccentric hypertrophy 1.71 1.02–2.87 0.040 7.66 3.83–15.3 <0.0001
Table 4. Factors associated with a high LAVI and a low LVEF according to multivariate logistic regression 
analysis. Abbreviations: OR = odds ratio; CI = confidence interval; RWT = relative wall thickness; LVMI = left 
ventricular mass index; HT = hypertension; DM = diabetes mellitus; CKD = chronic kidney disease, 
HLP = Hyperlipidemia.
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Eccentric hypertrophy is typically induced by volume overload, such as in valvular heart disease or systolic 
heart failure. The prevalence of systolic dysfunction is mostly noted in eccentric hypertrophy. Systolic dysfunc-
tion affects LV geometry through enlargement of the LV chamber. A large LV and low LVEF cause congestion 
of the left atrium21–23. Consequently, LA enlargement in eccentric hypertrophy is suggested to be highest among 
groups with pressure and volume overload. A larger LA volume is associated with a higher risk of AF15. In addi-
tion, patients with AF and patients with a larger LA showed a higher LVMI and a low LVEF in a sub-study of 
the AFFIRM trial25. In our study analysis of both AF and non-AF populations, LA enlargement and LVEF were 
significantly related to LV geometric remodeling. Therefore, the rate of AF was increasing per the LV remode-
ling patterns. This was true for patients with non-valvular AF. The prevalence of LVH was high in patients with 
non-valvular AF26. Patel et al. reported that LAVI was associated only with LVMI, not RWT21. This is consistent 
with our present study which showed that the relationship between LA size and RWT was different for normal 
and high LVMI.
In addition, LAVI and LVEF accurately predicted the presence of AF in our study; therefore, we performed 
multivariate analyses excluding these co-linear factors. A linear association with LVMI and LA enlargement was 
observed; however, the effect of RWT on a low LVEF was different between patients with a normal LVMI and 
those with a high LVMI. Because LV geometric remodeling was clearly associated with LA enlargement and a low 
LVEF, a schematic in which that LV morphology was linked to the LV function and LA size is provided (Fig. 4F). 
Furthermore, the LV morphology was linked to the prognosis7,26. Thromboembolic events may be one of the 
mechanisms for the higher mortality in LVH27. Although there are reportedly many factors related to AF and LA 
enlargement, such as age, the presence of hypertension, and obesity24, LV geometric remodeling has an impact 
on the presence of AF through the association with LA enlargement and a low LVEF. However, atrial fibrillation 
can develop without left atrial enlargement28. Atrial size increases with time in patients with atrial fibrillation, 
without any structural or functional abnormality of LV and the valve28. Since our study is cross-sectional, we 
could not identify the cause-effect relationship in each patient. Longitudinal follow-up could address this issue 
in each patient.
In clinical practice, LVH is a risk factor in hypertensive patients29 and severe AS patients30. In our study, we 
provided the link between LV geometric patterns and AF prevalence through the contribution of atrial enlarge-
ment and decreased LVEF. AF and LA enlargement is a risk factor for ischemic stroke and may contribute to dou-
bling all-cause31 and CV deaths14, and, in a specific condition, non-CV deaths32. However, anticoagulants were 
sub-optimally prescribed in these patients. Attention should be paid to paroxysmal AF in the LVH population to 
improve our daily practice.
There are several limitations to the present study. First, the subjects are heterogeneous because of the TTE and 
ECG findings. The ordering criteria for ECG and TTE were not set. Second, patients’ data were extracted from 
electronic medical data. A lack of information regarding exercise was an important limitation24. Third, we did 
not consider the effect of valvular diseases such as mitral valve regurgitation. Fourth, patients with short-lasting 
paroxysmal AF were excluded, because we included patients with AF when they had an AF rhythm according 
to an ECG examination. Lastly, the data presented provide only hypothesis-generating associations between LV 
geometry and AF. Since this study had a cross-sectional design, a cause-effect relationship could not be assessed. 
Further prospective studies are needed to determine the association of LA remodeling, LV geometric changes, LV 
function, mortality, and the time-course for the development of AF.
Conclusions
The prevalence of AF was increasing according to LV geometric remodeling patterns in association with LA size 
and LVEF.
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